{{Rsnum
|rsid=56350726
|Gene=SLC28A3
|Chromosome=9
|position=84285454
|Orientation=plus
|GMAF=0.08999
|Gene_s=SLC28A3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{PMID Auto
|PMID=22118055
|Title=Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy
}}

{{PMID|21346688}} Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C.

{{GET Evidence
|gene=SLC28A3
|aa_change=Tyr513Phe
|aa_change_short=Y513F
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs56350726
|overall_frequency_n=945
|overall_frequency_d=10758
|overall_frequency=0.0878416
|n_genomes=8
|n_genomes_annotated=0
|n_haplomes=9
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.504
|nblosum100=-4
|autoscore=0
|webscore=N
}}

{{PMID Auto
|PMID=23195617
|Title=Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}